Effect of Non-Invasive Neuromodulation on Primary Chronic Pain, Including Post-COVID-19
NCT06689345 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 55
Last updated 2024-11-14
Summary
The aim of this study is to analyse whether there is an advantage in adding low-intensity electrical stimulations to the vagus nerve with electrodes in the outer ear to control pain and fatigue in people with primary chronic pain, and in people who have had COVID-19. Several studies have shown that many people with primary chronic pain and also people who have had COVID patients continue to have pain and fatigue that may be due to changes that occur in the brain and the vagus nerve that passes through the neck might cause inflammation. Therefore the aim of this study is to investigate if these electrical stimulations can help improve the condition of the brain and nerve and consequently, the inflammation so that these complaints improve.
This study will be organized as the following: It will begin with an assessment, divided into a part with questionnaires and another with specific tests. The questionnaires are aimed at understanding volunteer's characteristics, pain, fatigue, inflammation, sleep, quality of life, and the presence of symptoms of anxiety and depression. Next, the volunteer will undergo two tests to assess the behavior of his/her brain. They are performed using EEG electroencephalography and transcranial magnetic stimulation (TMS).
* Quantitative EEG at rest - In this technique, a cap with electrodes is placed on volunteer's head, in contact with hair, which are connected through a gel. The volunteer needs to remain still for 6 minutes with eyes closed, sitting in a comfortable chair.
* TMS with EEG - First, the volunteer will be asked to honestly answer the questions in the safety questionnaire for using this technique. Honest answers will eliminate the risks associated with this evaluation. Next, the volunteer's skin will be cleaned with alcohol and a special paste and place three self-adhesive electrodes on the muscle of the volunteer's hand, in a muscle called the interosseous, on the side where he/she writes. These electrodes will only capture the electrical activity of the muscle. Next, a series of magnetic pulses will be administered to the volunteer's skull, in the area that controls the hand muscle. It will contract with each pulse and, with this, so that the functioning of this connection can be understood. At the same time, the EEG device will capture the brain activities that occur during this TMS stimulation. During this exam, the volunteer may feel anything from no stimulation to muscle contractions that move his/her hand. Some people also experience redness under the electrodes, fatigue, or muscle/joint pain.
After the assessments, volunteers will be randomly selected to receive neuromodulation sessions using low-intensity electrical stimulation of the vagus nerve, using electrodes in the outer ear (active group), or sessions that only simulate this neuromodulation (sham, or placebo, group). This will occur for five consecutive days, starting on the day of the assessment. This stimulation is very weak and may not even be felt by the person receiving it. This technique is safe and the most that may occur is redness or itching of the skin. A few people may also experience tingling, a burning sensation or momentary local pain, fatigue, drowsiness, difficulty concentrating and a feeling of nervousness during or after the stimulation.
At the end of the 5 days of electrical stimulation, the same initial assessments will be repeated to see if anything has changed in the volunteer's brain, heart rate, blood pressure, pain, fatigue, inflammation, sleep, quality of life, depression, and anxiety.
Conditions
- Post COVID Condition
- Chronic Pain
- Healthy
Interventions
- DEVICE
-
taVNS - transauricular vagal nerve stimulation
30 minutes of electrical stimulation on the afferent portion of the vagal nerve on the cymba conchae of the ear, in the following configuration: 30 seg ramp up, 30 seg on, 30 seg off in intensity on which the volunteer feels a light tingling.
- DEVICE
-
rPMS - repetitive peripheric magnetic stimulation
Magnetic stimulation on the efferent portion of the vagal nerve on the neck, on the following configuration: 20Hz, 25 pulses in the trein, in every inhalation, for 20 inhalations with 50% of machine capacity (500 pulses total).
- DEVICE
-
rTMS - repetitive transcranial magnetic stimulation
rTMS intermitent theta- burst on the left DLPFC, on the following configuration: 50 Hz in treins of 5Hz, with 110% of the resting motor limiar and 600 pulses in 3 minutes.
- DEVICE
-
taVNS sham
Simulated taVNS (SHAM) on helix left ear, that is the same as taVNS, but during only 1 minute
Sponsors & Collaborators
-
University of Sao Paulo
collaborator OTHER -
Coordination for the Improvement of Higher Education Personnel
collaborator OTHER -
Federal University of ABC
lead OTHER
Principal Investigators
-
Tiago S Lopes, PhD · Federal University of ABC
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- SEQUENTIAL
Eligibility
- Min Age
- 18 Years
- Max Age
- 64 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2024-04-21
- Primary Completion
- 2024-12-16
- Completion
- 2024-12-16
Countries
- Brazil
More Related Trials
-
Interventional Neuromodulation in Fibromyalgia
NCT06373445 ·Status: RECRUITING ·Phase: NA
-
Study of RTMS Analgesic Effect in Chronic Neuropathic Pain,
NCT04936646 ·Status: RECRUITING ·Phase: NA
-
Deep rTMS in Central Neuropathic Pain Syndromes
NCT01932905 ·Status: COMPLETED ·Phase: NA
-
rTMS as a Treatment of Neuropathic Pain Secondary to Malignancy
NCT02078479 ·Status: COMPLETED ·Phase: NA
-
Analgesic Effects of rTMS in Peripheral Neuropathic Pain
NCT02010281 ·Status: COMPLETED ·Phase: NA
-
Neuromodulation in Patients With Neuropathic Pain and Depression.
NCT06129890 ·Status: RECRUITING ·Phase: NA
-
Analgesic Effect of Non Invasive Stimulation : Comparison of rTMS and tDCS Efficacy
NCT01800136 ·Status: COMPLETED ·Phase: NA
-
Analgesic Stimulation Non-invasive of the Motor Cortex
NCT02854332 ·Status: UNKNOWN ·Phase: NA
-
Effect of Multitarget tDCS for Neuropathic Pain
NCT06510725 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Comparison of the Efficacy of rTMS and tDCS of the Motor Cortex in Patients With Chronic Neuropathic Pain
NCT02030626 ·Status: COMPLETED ·Phase: PHASE4
-
Transcranial Magnetic Stimulation for Chronic Neuropathic Pain
NCT05593237 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Analgesic Effect of Accelerated Repetitive Transcranial Magnetic Stimulation in Neuropathic Pain
NCT05295498 ·Status: RECRUITING ·Phase: NA
-
Neuronavigated Repetitive Transcranial Magnetic Stimulation (nrTMS) of the Dorsolateral Prefrontal and Primary Motor Cortex for the Treatment of Chronic Pain
NCT04934150 ·Status: COMPLETED ·Phase: NA
-
Electroencephalography-based Precise Repetitive Transcranial Magnetic Stimulation Treatment
NCT06385405 ·Status: RECRUITING ·Phase: NA
-
Transcranial Magnetic Stimulation (TMS) Effects on Pain Perception
NCT00349050 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3
-
Analgesic Effect of Repetitive Transcranial Magnetic Stimulation (rTMS) for Central Neuropathic Pain in Multiple Sclerosis
NCT02059096 ·Status: UNKNOWN ·Phase: PHASE3
-
Symptom-specific TMS Targets for Depression and Anxiety
NCT04604210 ·Status: COMPLETED ·Phase: PHASE2
-
Protocol Assessment of Motor Cortex rTMS for Treating Neuropathic Pain
NCT06964243 ·Status: RECRUITING ·Phase: NA
-
Electro-Magnetic Convulsive Therapies for Depression: a Non-inferiority Study
NCT05054699 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3
-
Repetitive Transcranial Magnetic Stimulation (rTMS) in Fibromyalgia
NCT03909009 ·Status: COMPLETED ·Phase: NA
-
TMS With Real-time E-field and EEG Source Imaging
NCT06645613 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
rTMS Efficacy Coupled With Mirror Therapy
NCT04867187 ·Status: RECRUITING ·Phase: NA
-
Effects of PrTMS on Performance
NCT05353244 ·Status: WITHDRAWN ·Phase: NA
-
Objective Diagnosis Method and Efficacy of Repetitive Transcranial Magnetic Stimulation as a Treatment for Tinnitus
NCT02617953 ·Status: UNKNOWN ·Phase: NA
-
Neuromodulation in COVID-19 Patients
NCT04808284 ·Status: COMPLETED ·Phase: PHASE1/PHASE2